The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves
Trial ID or NCT#
NCT01314313
Status
NOT RECRUITING
Purpose
The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN XT and the Edwards SAPIEN 3 transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, severe aortic stenosis.
Official Title
Edwards SAPIEN XT Transcatheter Heart Valve Therapy for Intermediate and High Risk Patients
Investigator(s)
D. Craig Miller, M.D.
Cardiovascular surgeon
Thelma and Henry Doelger Professor of Cardiovascular Surgery, Emeritus
Rajesh Dash, MD PhD; Director of SSATHI & CardioClick
Cardiologist
Associate Professor of Medicine (Cardiovascular Medicine)
Contact us to find out if this trial is right for you.
Contact
Martina Kelly Speight
6507252687
View on ClinicalTrials.gov
